Microtech, a wholly owned subsidiary of Medinol, is happy to announce the first U.S. implantations of its atrial-pressure microsensor. Two surgical implantations were performed on Friday, May 16, 2025, at New York-Presbyterian/Columbia University Irving Medical Center by Dr. Koji Takeda, Surgical Director for Adult Heart Transplant at New York-Presbyterian/Columbia. The Microtech atrial-pressure microsensor is a new class of device, characterized by an extremely small size, entirely passive nature, the absence of any electronics or antenna and its ability to receive and transmit signals via ultrasound. Due to these properties, the Microtech sensors can be used not only as a stand-alone device but can also be integrated onto existing implants, turning them into combination therapeutic-diagnostic smart devices, capable of gathering data and performing multiple functions at once.  The two sensors, implanted in patients who received LVADs at New York-Presbyterian/Columbia, join the… 

A research team led by Dr. Der-Yang Cho, Superintendent of China Medical University Hospital (Taiwan), in collaboration with Shine-On Biomedical Co., has developed the world’s first targeted exosome drug delivery platform aimed at HLA-G, marking a major milestone in the field of precision oncology. The novel platform, named SOB100, has completed preclinical studies and demonstrated promising efficacy in treating aggressive cancers such as breast cancer and glioblastoma. The team’s findings were published in the prestigious journal Nature Communications, and on March 8, 2025, the platform received approval from the U.S. Food and Drug Administration (FDA) to begin Phase I clinical trials in humans.

An estimated 11 to 12 million people without valid residency status live in the United States. These so-called undocumented immigrants, often from Mexico, Central America, or other Latin American countries, are an integral part of U.S. society and particularly the labor market. They work in sectors such as agriculture, construction, hospitality, cleaning, and care – jobs that are often poorly paid and frequently avoided by U.S. citizens. At the same time, they are the target of a polarizing political debate that has been intensified in recent years by Donald Trump. His promises of mass deportations and a hard line against illegal immigration shape the political landscape, but a closer look reveals: Trump's policy is not only unrealistic but also deceitful, as it ignores the economic dependence of the U.S. on these workers and reduces the complexity of the problem to simple narratives. Undocumented Immigrants and the Labor Market Undocumented immigrants make up about five… 

The debate about assisted suicide in the United States is as old as it is controversial. In a country characterized by its cultural diversity and strong individual freedoms, the question of the right to a self-determined end of life presents an ethical, legal, and societal challenge. While some states have enacted laws that permit physician-assisted suicide under strict conditions, the topic remains taboo in other regions, shaped by religious, moral, and medical concerns. This report sheds light on the current situation of assisted suicide in the USA, its legal framework, societal discussions, and the resulting challenges. The legal situation: A patchwork of laws In the USA, assisted suicide, particularly physician-assisted suicide, is not a uniformly regulated issue nationwide. Legislation is the responsibility of individual states, leading to a fragmented picture. Currently, ten states allow…